Remedium Bio is a Boston based gene therapy company focused on the development of highly innovative treatments for a broad range of diseases. The Remedium approach utilizes proven scientific fundamentals, in a novel way, to treat the most debilitating conditions. Starting with well-characterized pathophysiological principles, our scientists modularly apply proven technologies to quickly advance curative treatments through the R&D cycle. Today, our leading candidates include gene therapy treatments in the fields of Endocrinology, Cardiology, Hematology, and Rheumatology.
Location: United States, Massachusetts, Needham
Employees: 1-10
Total raised: $2.3M
Founded date: 2020
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.08.2022 | Seed | $2.3M | - |
Mentions in press and media 6
| Date | Title | Description |
| 12.09.2024 | A New Dawn in Gene Therapy: LifeSpan Vision Ventures Backs Remedium Bio | In the ever-evolving landscape of biotechnology, a new player is making waves. Remedium Bio, a Needham, Massachusetts-based company, has secured a significant investment from LifeSpan Vision Ventures. This partnership aims to propel Remediu... |
| 11.09.2024 | Remedium Bio Receives Investment from LifeSpan Vision Ventures | Remedium Bio, a Needham, MA-based biotechnology company focused on the development of treatments for large unmet clinical needs, received an investment from LifeSpan Vision Ventures. The amount of the deal was not disclosed. The company int... |
| 10.09.2024 | LifeSpan Vision Ventures Invests in Remedium Bio | NORWALK, Conn., Sept. 10, 2024 /PRNewswire/ -- LifeSpan Vision Ventures today announced that it has closed an investment in Remedium Bio. - The biotechnology company is developing a first-in-class adjustable-dose gene therapy platform calle... |
| 16.08.2022 | Remedium Bio Closes $2.3M Expanded Seed Funding | Remedium Bio, a Boston, MA-based biotechnology company, raised $2.3M in Expanded Seed funding. The round was led by Sherwood Ventures with participation from, LongevityTech.Fund, Primo Medical Group, Angel Star Ventures, Apis Health Angels,... |
| 15.08.2022 | Remedium Bio Announces $2.3M Expanded Seed raise | BOSTON, MA, Remedium Bioa biotechnology company developing, has closed more than $2.3M in its expanded seed round financing led by Sherwood Ventures. >> Click here for more funding data on Remedium Bio >> To export Remedium ... |
| 15.09.2021 | Remedium Bio announces research agreement with a leading Rheumatology laboratory |